ID   A1CF_HUMAN              Reviewed;         594 AA.
AC   Q9NQ94; Q5SZQ0; Q9NQ93; Q9NQX8; Q9NQX9; Q9NXC9; Q9NZD3;
DT   20-DEC-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2000, sequence version 1.
DT   05-MAY-2009, entry version 69.
DE   RecName: Full=APOBEC1 complementation factor;
DE   AltName: Full=APOBEC1-stimulating protein;
GN   Name=A1CF; Synonyms=ACF, ASP;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), FUNCTION, AND
RP   INTERACTION WITH APOBEC1.
RC   TISSUE=Liver, and Small intestine;
RX   MEDLINE=20347895; PubMed=10781591; DOI=10.1074/jbc.M001786200;
RA   Lellek H., Kirsten R., Diehl I., Apostel F., Buck F., Greeve J.;
RT   "Purification and molecular cloning of a novel essential component of
RT   the apolipoprotein B mRNA editing enzyme-complex.";
RL   J. Biol. Chem. 275:19848-19856(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), FUNCTION, INTERACTION WITH
RP   APOBEC1, AND TISSUE SPECIFICITY.
RX   MEDLINE=20136062; PubMed=10669759;
RX   DOI=10.1128/MCB.20.5.1846-1854.2000;
RA   Mehta A., Kinter M.T., Sherman N.E., Driscoll D.M.;
RT   "Molecular cloning of APOBEC-1 complementation factor, a novel RNA-
RT   binding protein involved in the editing of apolipoprotein B mRNA.";
RL   Mol. Cell. Biol. 20:1846-1854(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 2 AND 3).
RC   TISSUE=Liver;
RA   Sowden M.P., Smith H.C.;
RT   "Human APOBEC-1 complementation factor related protein.";
RL   Submitted (MAY-2000) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Cahill P., Camire D.,
RA   Carter N.P., Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Corby N., Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L.,
RA   Frankish A., Frankland J.A., Garner P., Garnett J., Gribble S.,
RA   Griffiths C., Grocock R., Gustafson E., Hammond S., Harley J.L.,
RA   Hart E., Heath P.D., Ho T.P., Hopkins B., Horne J., Howden P.J.,
RA   Huckle E., Hynds C., Johnson C., Johnson D., Kana A., Kay M.,
RA   Kimberley A.M., Kershaw J.K., Kokkinaki M., Laird G.K., Lawlor S.,
RA   Lee H.M., Leongamornlert D.A., Laird G., Lloyd C., Lloyd D.M.,
RA   Loveland J., Lovell J., McLaren S., McLay K.E., McMurray A.,
RA   Mashreghi-Mohammadi M., Matthews L., Milne S., Nickerson T.,
RA   Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A., Ross M.T.,
RA   Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W.,
RA   Tracey A., Tromans A., Tsolas J., Wall M., Walsh J., Wang H.,
RA   Weinstock K., West A.P., Willey D.L., Whitehead S.L., Wilming L.,
RA   Wray P.W., Young L., Chen Y., Lovering R.C., Moschonas N.K.,
RA   Siebert R., Fechtel K., Bentley D., Durbin R.M., Hubbard T.,
RA   Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [6]
RP   GENE STRUCTURE, AND ALTERNATIVE SPLICING.
RX   MEDLINE=21575688; PubMed=11718896; DOI=10.1016/S0167-4781(01)00295-0;
RA   Henderson J.O., Blanc V., Davidson N.O.;
RT   "Isolation, characterization and developmental regulation of the human
RT   apobec-1 complementation factor (ACF) gene.";
RL   Biochim. Biophys. Acta 1522:22-30(2001).
RN   [7]
RP   IDENTIFICATION IN A COMPLEX WITH APOBEC1 AND CUGBP2.
RX   PubMed=11577082; DOI=10.1074/jbc.M104911200;
RA   Anant S., Henderson J.O., Mukhopadhyay D., Navaratnam N., Kennedy S.,
RA   Min J., Davidson N.O.;
RT   "Novel role for RNA-binding protein CUGBP2 in mammalian RNA editing.
RT   CUGBP2 modulates C to U editing of apolipoprotein B mRNA by
RT   interacting with apobec-1 and ACF, the apobec-1 complementation
RT   factor.";
RL   J. Biol. Chem. 276:47338-47351(2001).
RN   [8]
RP   RNA-BINDING DOMAIN, AND MUTAGENESIS OF PHE-59; PHE-100; PHE-139;
RP   PHE-183; TYR-234 AND PHE-270.
RX   MEDLINE=21860382; PubMed=11871661; DOI=10.1017/S1355838202015649;
RA   Mehta A., Driscoll D.M.;
RT   "Identification of domains in apobec-1 complementation factor required
RT   for RNA binding and apolipoprotein-B mRNA editing.";
RL   RNA 8:69-82(2002).
RN   [9]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=12881431; DOI=10.1093/emboj/cdg369;
RA   Chester A., Somasekaram A., Tzimina M., Jarmuz A., Gisbourne J.,
RA   O'Keefe R., Scott J., Navaratnam N.;
RT   "The apolipoprotein B mRNA editing complex performs a multifunctional
RT   cycle and suppresses nonsense-mediated decay.";
RL   EMBO J. 22:3971-3982(2003).
RN   [10]
RP   NUCLEAR LOCALIZATION SIGNAL, AND INTERACTION WITH TNPO2.
RX   PubMed=12896982; DOI=10.1074/jbc.M302951200;
RA   Blanc V., Kennedy S., Davidson N.O.;
RT   "A novel nuclear localization signal in the auxiliary domain of
RT   apobec-1 complementation factor regulates nucleocytoplasmic import and
RT   shuttling.";
RL   J. Biol. Chem. 278:41198-41204(2003).
RN   [11]
RP   STRUCTURE BY NMR OF 223-308.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of the RNA recognition motif of human APOBEC-1
RT   complementation factor, ACF.";
RL   Submitted (NOV-2005) to the PDB data bank.
CC   -!- FUNCTION: Essential component of the apolipoprotein B mRNA editing
CC       enzyme complex which is responsible for the postranscriptional
CC       editing of a CAA codon for Gln to a UAA codon for stop in APOB
CC       mRNA. Binds to APOB mRNA and is probably responsible for docking
CC       the catalytic subunit, APOBEC1, to the mRNA to allow it to
CC       deaminate its target cytosine. The complex also protects the
CC       edited APOB mRNA from nonsense-mediated decay.
CC   -!- SUBUNIT: Part of the apolipoprotein B mRNA editing complex with
CC       APOBEC1. Found in a complex with APOBEC1 and CUGBP2. Interacts
CC       with KHSRP/KRSP which is not required for APOBEC1 activity but
CC       which may confer stability on the editing complex. Also interacts
CC       with the nuclear import protein TNPO2/TRN2 which may be
CC       responsible for its transport into the nucleus.
CC   -!- SUBCELLULAR LOCATION: Nucleus. Endoplasmic reticulum (By
CC       similarity). Cytoplasm. Note=Predominantly nuclear where it
CC       localizes to heterochromatin. Also cytoplasmic where it is found
CC       at the outer surface of the endoplasmic reticulum (By similarity).
CC       Shuttles between the nucleus and cytoplasm. May be transported
CC       into the nucleus by the nuclear import protein TNPO2/TRN2 or by
CC       APOBEC1.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=6;
CC       Name=1;
CC         IsoId=Q9NQ94-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9NQ94-2; Sequence=VSP_051929;
CC         Note=Major isoform found in 66-78% of cDNA clones;
CC       Name=3;
CC         IsoId=Q9NQ94-3; Sequence=VSP_051926, VSP_051929;
CC       Name=4;
CC         IsoId=Q9NQ94-4; Sequence=VSP_051927, VSP_051929;
CC         Note=No experimental confirmation available. Does not exhibit
CC         APOBEC1 complementation activity;
CC       Name=5;
CC         IsoId=Q9NQ94-5; Sequence=VSP_051925;
CC         Note=Does not exhibit APOBEC1 complementation activity;
CC       Name=6;
CC         IsoId=Q9NQ94-6; Sequence=VSP_051928;
CC         Note=Minor isoform found in 2-3% of cDNA clones;
CC   -!- TISSUE SPECIFICITY: Widely expressed with highest levels in brain,
CC       liver, pancreas, colon and spleen.
CC   -!- DOMAIN: The RRM domains are necessary but not sufficient for
CC       binding to APOB mRNA. Additional residues in the pre-RRM and C-
CC       terminal regions are required for RNA-binding and for
CC       complementing APOBEC1 activity.
CC   -!- SIMILARITY: Contains 3 RRM (RNA recognition motif) domains.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA91086.1; Type=Frameshift; Positions=148;
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AJ272078; CAB94754.1; -; mRNA.
DR   EMBL; AJ272079; CAB94755.1; -; mRNA.
DR   EMBL; AF209192; AAF34824.1; -; mRNA.
DR   EMBL; AF271789; AAF76221.1; -; mRNA.
DR   EMBL; AF271790; AAF76222.1; -; mRNA.
DR   EMBL; AK000324; BAA91086.1; ALT_FRAME; mRNA.
DR   EMBL; AL512366; CAI14233.1; -; Genomic_DNA.
DR   EMBL; AL589794; CAI14233.1; JOINED; Genomic_DNA.
DR   EMBL; AL512366; CAI14235.1; -; Genomic_DNA.
DR   EMBL; AL589794; CAI14235.1; JOINED; Genomic_DNA.
DR   EMBL; AL512366; CAI14236.1; -; Genomic_DNA.
DR   EMBL; AL589794; CAI14236.1; JOINED; Genomic_DNA.
DR   EMBL; AL589794; CAI15762.1; -; Genomic_DNA.
DR   EMBL; AL512366; CAI15762.1; JOINED; Genomic_DNA.
DR   EMBL; AL589794; CAI15763.1; -; Genomic_DNA.
DR   EMBL; AL512366; CAI15763.1; JOINED; Genomic_DNA.
DR   EMBL; AL589794; CAI15764.1; -; Genomic_DNA.
DR   EMBL; AL512366; CAI15764.1; JOINED; Genomic_DNA.
DR   IPI; IPI00071360; -.
DR   IPI; IPI00148257; -.
DR   IPI; IPI00299499; -.
DR   IPI; IPI00657723; -.
DR   IPI; IPI00657770; -.
DR   IPI; IPI00657992; -.
DR   RefSeq; NP_055391.2; -.
DR   RefSeq; NP_620310.1; -.
DR   RefSeq; NP_620311.1; -.
DR   UniGene; Hs.499643; -.
DR   PDB; 2CPD; NMR; -; A=223-308.
DR   PDBsum; 2CPD; -.
DR   SMR; Q9NQ94; 128-230.
DR   PhosphoSite; Q9NQ94; -.
DR   PRIDE; Q9NQ94; -.
DR   Ensembl; ENSG00000148584; Homo sapiens.
DR   GeneID; 29974; -.
DR   KEGG; hsa:29974; -.
DR   GeneCards; GC10M052237; -.
DR   H-InvDB; HIX0004173; -.
DR   H-InvDB; HIX0008828; -.
DR   HGNC; HGNC:24086; A1CF.
DR   HOVERGEN; Q9NQ94; -.
DR   OMA; Q9NQ94; AFPGYAV.
DR   Reactome; REACT_1675; mRNA Processing.
DR   NextBio; 52719; -.
DR   ArrayExpress; Q9NQ94; -.
DR   Bgee; Q9NQ94; -.
DR   CleanEx; HS_A1CF; -.
DR   GermOnline; ENSG00000148584; Homo sapiens.
DR   GO; GO:0030895; C:apolipoprotein B mRNA editing enzyme complex; IDA:UniProtKB.
DR   GO; GO:0005783; C:endoplasmic reticulum; IEA:UniProtKB-KW.
DR   GO; GO:0000166; F:nucleotide binding; IEA:InterPro.
DR   GO; GO:0005515; F:protein binding; IPI:UniProtKB.
DR   GO; GO:0003727; F:single-stranded RNA binding; IDA:UniProtKB.
DR   GO; GO:0006397; P:mRNA processing; IEA:UniProtKB-KW.
DR   GO; GO:0050821; P:protein stabilization; IDA:UniProtKB.
DR   InterPro; IPR012677; a_b_plait_nuc_bd.
DR   InterPro; IPR006535; HnRNP_R_Q.
DR   InterPro; IPR000504; RRM_RNP1.
DR   Gene3D; G3DSA:3.30.70.330; a_b_plait_nuc_bd; 3.
DR   Pfam; PF00076; RRM_1; 3.
DR   SMART; SM00360; RRM; 3.
DR   TIGRFAMs; TIGR01648; hnRNP-R-Q; 1.
DR   PROSITE; PS50102; RRM; 3.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cytoplasm; Endoplasmic reticulum;
KW   mRNA processing; Nucleus; Polymorphism; Repeat; RNA-binding.
FT   CHAIN         1    594       APOBEC1 complementation factor.
FT                                /FTId=PRO_0000081482.
FT   DOMAIN       56    134       RRM 1.
FT   DOMAIN      136    218       RRM 2.
FT   DOMAIN      231    303       RRM 3.
FT   REGION      360    409       Required for nuclear localization.
FT   VAR_SEQ       1     84       Missing (in isoform 5).
FT                                /FTId=VSP_051925.
FT   VAR_SEQ       1     33       MESNHKSGDGLSGTQKEAALRALVQRTGYSLVQ -> MLCS
FT                                PSFCKLCWKRKK (in isoform 3).
FT                                /FTId=VSP_051926.
FT   VAR_SEQ       1     33       MESNHKSGDGLSGTQKEAALRALVQRTGYSLVQ -> MEAV
FT                                CLGTCPEPEASMSTAIPGLKKGNNALQSIILQTLLEK (in
FT                                isoform 4).
FT                                /FTId=VSP_051927.
FT   VAR_SEQ     202    256       Missing (in isoform 6).
FT                                /FTId=VSP_051928.
FT   VAR_SEQ     381    388       Missing (in isoform 2, isoform 3 and
FT                                isoform 4).
FT                                /FTId=VSP_051929.
FT   VARIANT     555    555       V -> M (in dbSNP:rs9073).
FT                                /FTId=VAR_052201.
FT   MUTAGEN      59     59       F->A: Greatly reduced RNA binding.
FT   MUTAGEN     100    100       F->A: Greatly reduced RNA binding.
FT   MUTAGEN     139    139       F->A: Greatly reduced RNA binding.
FT   MUTAGEN     183    183       F->A: Greatly reduced RNA binding.
FT   MUTAGEN     234    234       Y->A: Slightly reduced RNA binding.
FT   MUTAGEN     270    270       F->A: Slightly reduced RNA binding.
FT   CONFLICT    191    191       A -> T (in Ref. 2; AAF34824).
FT   CONFLICT    277    277       E -> K (in Ref. 2 and 3).
SQ   SEQUENCE   594 AA;  65202 MW;  AA5EF76BD8815807 CRC64;
     MESNHKSGDG LSGTQKEAAL RALVQRTGYS LVQENGQRKY GGPPPGWDAA PPERGCEIFI
     GKLPRDLFED ELIPLCEKIG KIYEMRMMMD FNGNNRGYAF VTFSNKVEAK NAIKQLNNYE
     IRNGRLLGVC ASVDNCRLFV GGIPKTKKRE EILSEMKKVT EGVVDVIVYP SAADKTKNRG
     FAFVEYESHR AAAMARRKLL PGRIQLWGHG IAVDWAEPEV EVDEDTMSSV KILYVRNLML
     STSEEMIEKE FNNIKPGAVE RVKKIRDYAF VHFSNREDAV EAMKALNGKV LDGSPIEVTL
     AKPVDKDSYV RYTRGTGGRG TMLQGEYTYS LGQVYDPTTT YLGAPVFYAP QTYAAIPSLH
     FPATKGHLSN RAIIRAPSVR EIYMNVPVGA AGVRGLGGRG YLAYTGLGRG YQVKGDKRED
     KLYDILPGME LTPMNPVTLK PQGIKLAPQI LEEICQKNNW GQPVYQLHSA IGQDQRQLFL
     YKITIPALAS QNPAIHPFTP PKLSAFVDEA KTYAAEYTLQ TLGIPTDGGD GTMATAAAAA
     TAFPGYAVPN ATAPVSAAQL KQAVTLGQDL AAYTTYEVYP TFAVTARGDG YGTF
//

